Jibon Health Technologies, Inc.

We are pleased to announce that Jibon Health Technologies, Inc., in partnership with icddr,b, has been chosen as a recipient of the 2014 Saving Lives at Birth: A Grand Challenge for Development seed grant sponsored by USAID, the Norwegian Ministry of Foreign Affairs, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and UKAID. This funding will help us to conduct Phase 1 & 2 clinical trials of Tampostat in Bangladesh. Thank you to everybody for your continued support!

––––––––––––––––

Jibon Health Technologies, Inc. is a social enterprise founded by a group of young professionals driven to solve global health problems through creative engineering. In the two years since founding, Jibon has seen critical acclaim and international press for their efforts to bring an end to postpartum hemorrhage (PPH) throughout the developing world with Tampostat™, a low-cost emergency obstetric device designed for use by midwives and traditional birth attendants.

The Jibon Health team consists of recent college graduates with unique backgrounds in biomedical engineering research, public health fieldwork, product development, and marketing. A board of expert advisors are helping to navigate the professional landscape and have established connections for business development both in the United States and abroad in countries most in need of this life-saving technology. With upcoming business development trips to China and Bangladesh, Jibon is excited to be working toward realizing its goal of affordable and simple healthcare solutions for all.

AWARDS & RECOGNITION
• Recipients: 2014 Saving Lives at Birth: A Grand Challenge for Development seed grant
• 2nd Prize: 2013 NAPEC Innovation Conference
• 2nd Prize: 2013 Columbia University Business Plan Competition
• Participants: Inaugural NYCEDC Bio & Health Tech Entrepreneurship Lab NYC
• Winners: 2012 Columbia University Business Pitch Competition
• Winner: 2012 Columbia University Capstone Award

Company’s Keywords:

medical devices, medical, health care, maternal health, biotechnology, social enterprise, global health, international development, technology transfer, clinical trials